Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Aprepitant
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Merck Sharp & Dohme LLC